By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cancer Prevention Pharmaceuticals, Inc.  

1760 E. River Road, Suite 250

Tucson  Arizona   85718  U.S.A.
Phone: 520-908-7774 Fax: 520-232-2191


Company News
Cancer Prevention Pharma In Collaboration With The NCI And Vanderbilt University Medical Center Initiates Phase II Trial To Evaluate CPP-1X In Patients With High Risk Of Gastric Cancer 7/17/2017 6:47:37 AM
Independent Data Monitoring Committee Recommends Continuation Of Cancer Prevention Pharma’ Phase III Trial For Familial Adenomatous Polyposis Patients 6/12/2017 8:17:30 AM
Cancer Prevention Pharma Completes Target Enrollment In Pivotal Phase 3 Clinical Trial Evaluating CPP-1X/Sulindac In Patients With Familial Adenomatous Polyposis 4/4/2016 6:15:36 AM
Cancer Prevention Pharma Files for a $29 Million IPO 12/23/2015 7:24:41 AM
Cancer Prevention Pharmaceuticals, Inc. Announces Appointment Of Jon S. Saxe To Its Board Of Directors 7/23/2015 10:12:48 AM
Cancer Prevention Pharmaceuticals, Inc. And Tillotts Pharma AG Sign Licensing Agreement For CPP-1X/Sulindac In Europe And Japan 1/10/2014 9:28:02 AM
Cancer Prevention Pharmaceuticals, Inc. Release: Phase 3 Familial Adenomatous Polyposis (FAP) Trial Now Open For Enrollment 12/5/2013 9:25:09 AM
Cancer Prevention Pharmaceuticals, Inc. Announces Completion of Bridge Financing Round 8/24/2011 10:06:42 AM